New patient studies surrounding Retatrutide , specifically the 120 milligram formulation referred to as ZPHC, indicate a considerable impact on weight reduction and related health factors. Experts anticipate that this dual acting , targeting both GLP-1 and GIP receptors , may provide a substanti